Catalyst Wire Dossier Catalyst Wire Dossier

ABBV-722

· AbbVie
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ABBV-722, covering 2025-07-20 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of a Tablet Form of ABBV-722 Taken With and Without Food in Healthy Adult Participants [Phase 1]

See pricing